På fredagsmorgonen skrev GPX Medical ett stycke börshistoria, när man blev det första bolaget som ringde i Nasdaqs IPO-klocka på Medicon Village i Lund. Strax efter noteringsceremonin klev en glad Hanna Sjöström, vd för GPX Medical, tillsammans med Niclas Holmberg, noteringsansvarig på Nasdaq, in i BioStocks studio för en kort intervju. Se intervjun här: Intervju Biostock Studio

About GPX Medical

GPX Medical AB is revolutionizing neonatal intensive care with NEOLA®, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a cutting-edge technology that measures lung volume changes and oxygen gas concentration. NEOLA® has the potential to provide better care, fewer days in intensive care and healthier lives for preterm born infants. Founded in 2016 and headquartered in Lund, Sweden, GPX Medical is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to global health care.

For investors

Please contact CEO Hanna Sjöström for investment opportunities:
hanna.sjostrom@gpxmedical.se

Contact

GPX Medical AB
Tellusgatan 13
224 57 Lund
Sweden
info@gpxmedical.se

Organization number: 559069-9012